Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/108923
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Soto del Cerro, David | - |
dc.contributor.author | Altafaj, Xavier | - |
dc.contributor.author | Sindreu Balet, Carlos | - |
dc.contributor.author | Bayés, Àlex | - |
dc.date.accessioned | 2017-03-27T08:10:57Z | - |
dc.date.available | 2017-03-27T08:10:57Z | - |
dc.date.issued | 2014-02-06 | - |
dc.identifier.issn | 1942-0889 | - |
dc.identifier.uri | http://hdl.handle.net/2445/108923 | - |
dc.description.abstract | Alterations in glutamatergic neurotransmission have long been associated with psychiatric and neurodevelopmental disorders (PNDD), but only recent advances in high-throughput DNA sequencing have allowed interrogation of the prevalence of mutations in glutamate receptors (GluR) among afflicted individuals. In this review we discuss recent work describing GluR mutations in the context of PNDDs. Although there are no strict relationships between receptor subunit or type and disease, some interesting preliminary conclusions have arisen. Mutations in genes coding for ionotropic glutamate receptor subunits, which are central to synaptic transmission and plasticity, are mostly associated with intellectual disability and autism spectrum disorders. In contrast, mutations of metabotropic GluRs, having a role on modulating neural transmission, are preferentially associated with psychiatric disorders. Also, the prevalence of mutations among GluRs is highly heterogeneous, suggesting a critical role of certain subunits in PNDD pathophysiology. The emerging bias between GluR subtypes and specific PNDDs may have clinical implications. | - |
dc.format.extent | 6 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Landes Bioscience | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.4161/cib.27887 | - |
dc.relation.ispartof | Communicative & Integrative Biology, 2014, vol. 7, num. 1, p. e27887 | - |
dc.relation.uri | https://doi.org/10.4161/cib.27887 | - |
dc.rights | cc-by (c) Soto del Cerro, David et al., 2014 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Fonaments Clínics) | - |
dc.subject.classification | Receptors de neurotransmissors | - |
dc.subject.classification | Malalties mentals | - |
dc.subject.classification | Neurologia | - |
dc.subject.classification | Discapacitats mentals | - |
dc.subject.other | Neurotransmitter receptors | - |
dc.subject.other | Mental illness | - |
dc.subject.other | Neurology | - |
dc.subject.other | People with mental disabilities | - |
dc.title | Glutamate receptor mutations in psychiatric and neurodevelopmental disorders | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 633728 | - |
dc.date.updated | 2017-03-27T08:10:58Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 24605182 | - |
Appears in Collections: | Articles publicats en revistes (Fonaments Clínics) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
633728.pdf | 226.12 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License